Glepaglutide 20.0 mg/mL clinical trials

A 104-WEEK, MULTICENTER, SINGLE-ARM, LONG-TERM, PHASE 3 EXTENSION TRIAL INVESTIGATING THE SAFETY AND EFFICACY OF GLEPAGLUTIDE IN ADULT PATIENTS WITH SHORT BOWEL SYNDROME (SBS) COMPLETING THE EASE SBS 2 TRIAL

This study looks at a new medicine called glepaglutide for adults with short bowel syndrome. It checks how safe and effective it is over a long time, especially what side effects people might have and if it helps reduce their need for IV feeding.